CLASS.AUTOMAITE.CA

Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval

Open

As of 2026-07-30, the Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Key facts — Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval
CaseClass Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval
StatusOpen
Law firmClassAction.org
JurisdictionUSA
Filing deadlineSee case details

Last verified: 2026-07-30

Am I eligible for the Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval?

A class action lawsuit alleges that OPTASE eye treatments are misbranded because they include active ingredients that are not FDA-approved.

Check if you qualify →

How do I join the Class Action Lawsuit Alleges OPTASE Eye Treatments Are Misbranded Due to Lack of FDA Approval?

  1. Run the free 1-minute eligibility self-check.
  2. If you qualify, register your claim on the platform.
  3. Class members typically pay nothing unless money is recovered.

Other active class actions

← Browse all 3465+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.